Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
0.025% Capsaicin Gel for the Treatment of Painful Diabetic Neuropathy: A Randomized, Double-Blind, Crossover, Placebo-Controlled TrialKulkantrakorn, Kongkiat ; Lorsuwansiri, Chakraphong ; Meesawatsom, PongsatornPain practice, 2013-07, Vol.13 (6), p.497-503 [Periódico revisado por pares]United States: Blackwell Publishing LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trialREITAMO, S ; HARPER, J ; BOS, J. D ; CAMBAZARD, F ; BRUIJNZEEL-KOOMEN, C ; VALK, P ; SMITH, C ; MOSS, C ; VOBOZY, A ; PALATSI, RBritish journal of dermatology (1951), 2004-03, Vol.150 (3), p.554-562 [Periódico revisado por pares]London: BlackwellTexto completo disponível |
|
3 |
Material Type: Artigo
|
0.125% Ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusionOWEN, M. D ; D'ANGELO, R ; GERANCHER, J. C ; THOMPSON, J. M ; FOSS, M. L ; BABB, J. D ; EISENACH, J. CAnesthesia and analgesia, 1998-03, Vol.86 (3), p.527-531 [Periódico revisado por pares]Hagerstown, MD: LippincottTexto completo disponível |
|
4 |
Material Type: Artigo
|
0.1 mm ePTFE versus autologous pericardium for hand-sewn trileaflet valved conduit: a comparative studyZhang, Huifeng ; Ye, Ming ; Chen, Gang ; Jia, BingJournal of artificial organs, 2019-09, Vol.22 (3), p.207-213 [Periódico revisado por pares]Tokyo: Springer JapanTexto completo disponível |
|
5 |
Material Type: Artigo
|
0.25% Chlorhexidine Gluconate Gel: A Protective Topical MicrobicidePATTON, DOROTHY L. ; SWEENEY, YVONNE T. COSGROVE ; McKAY, TAMYRA L. ; DeMERS, SHAUNE M. ; CLARK, AGNES M. ; RABE, LORNA K. ; HILLIER, SHARON L.Sexually transmitted diseases, 1998-09, Vol.25 (8), p.421-424 [Periódico revisado por pares]Hagerstown, MD: Lippincott Williams & WilkinsTexto completo disponível |
|
6 |
Material Type: Artigo
|
0.5% Versus 1.0% 2-chloroprocaine for intravenous regional anesthesia: A prospective, randomized, double-blind trialMARSCH, Stephan C ; SLUGA, Mathias ; STUDER, Wolfgang ; BARANDUN, Jonas ; SCHARPLATZ, Domenic ; UMMENHOFER, WolfgangAnesthesia and analgesia, 2004-06, Vol.98 (6), p.1789-1793 [Periódico revisado por pares]Hagerstown, MD: LippincottTexto completo disponível |
|
7 |
Material Type: Artigo
|
0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushesGerlinger, C. ; Gude, K. ; Schmelter, T. ; Schaefers, M. ; Endrikat, J.Climacteric : the journal of the International Menopause Society, 2015-08, Vol.18 (4), p.512-517 [Periódico revisado por pares]England: Informa HealthcareTexto completo disponível |
|
8 |
Material Type: Artigo
|
0.5 Mb Array as a First-Line Prenatal Cytogenetic Test in Cases without Ultrasound Abnormalities and Its Implementation in Clinical PracticeSrebniak, Malgorzata I. ; Mout, Lisanne ; Van Opstal, Diane ; Galjaard, Robert-Jan H.Human mutation, 2013-09, Vol.34 (9), p.1298-1303 [Periódico revisado por pares]United States: Blackwell Publishing LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
0.9% NaCl (Normal Saline) – Perhaps not so normal after all?Blumberg, Neil ; Cholette, Jill M. ; Pietropaoli, Anthony P. ; Phipps, Richard ; Spinelli, Sherry L. ; Eaton, Michael P. ; Noronha, Suzie A. ; Seghatchian, Jerard ; Heal, Joanna M. ; Refaai, Majed A.Transfusion and apheresis science, 2018-02, Vol.57 (1), p.127-131 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trialWilliams, Vijai ; Jayashree, Muralidharan ; Nallasamy, Karthi ; Dayal, Devi ; Rawat, AmitCritical care (London, England), 2020-01, Vol.24 (1), p.1-1, Article 1 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |